200
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Novel Needle for Intravitreal Drug Delivery: Comparative Study of Needle Tip Aspirates, Injection Stream and Penetration Forces

ORCID Icon, ORCID Icon, , , , , & show all
Pages 723-734 | Published online: 19 Feb 2021

References

  • Fagan XJ, Al-Qureshi S. Intravitreal injections: a review of the evidence for best practice. Clin Exp Ophthalmol. 2013;41(5):500–507. doi:10.1111/ceo.12026
  • Campbell RJ, Bronskill SE, Bell CM, Paterson JM, Whitehead M, Gill SS. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol. 2010;128(3):359–362. doi:10.1001/archophthalmol.2010.19
  • Karth PA, Blumenkranz MS. Update on intravitreal injection techniques: on the anniversary of the consensus guidelines, a look at what evidence gathered over the decade has taught us. Rev Opthalmol. 2014;21:81–85.
  • Hartman RR, Kompella UB. Intravitreal, Subretinal, and suprachoroidal injections: evolution of microneedles for drug delivery. J Ocul Pharmacol Ther. 2018;34(1–2):141–153. doi:10.1089/jop.2017.0121
  • Avery RL, Bakri SJ, Blumenkranz MS, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34:S1–S18. doi:10.1097/IAE.0000000000000399
  • Shikari H, Samant PM. Intravitreal injections: a review of pharmacological agents and techniques. J Clin Ophthalmol Res. 2016;4(1):51–59. doi:10.4103/2320-3897.174429
  • Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:10.1128/CMR.00113-16
  • Qian Z, Li H, Tao Y, Li W. Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients. BMC Ophthalmol. 2018;18(1):314. doi:10.1186/s12886-018-0983-z
  • Manjandavida FP, Shields CL. The role of intravitreal chemotherapy for retinoblastoma. Indian J Ophthalmol. 2015;63(2):141–145. doi:10.4103/0301-4738.154390
  • Moisseiev E, Loewenstein A. [Intravitreal injection - a small procedure for the eye, a giant leap for ophthalmology]. Harefuah. 2019;158(2):121–125. Hebrew.
  • Van der Reis MI, La Heij EC, De Jong-hesse Y, Ringens PJ, Hendrikse F, Schouten JSAG. A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections. Retina. 2011;31(8):1449–1469. doi:10.1097/IAE.0b013e3182278ab4
  • Sigford DK, Reddy S, Mollineaux C, Schaal S. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis. Clin Ophthalmol. 2015;9:773–781. doi:10.2147/OPTH.S77067
  • Jonas JB, Spandau UH, Rensch F, Von Baltz S, Schlichtenbrede F. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J Ocul Pharmacol Ther. 2007;23(3):240–242. doi:10.1089/jop.2006.0146
  • Klein KS, Walsh MK, Hassan TS, et al. Endophthalmitis after anti-VEGF injections. Ophthalmology. 2009;116(6):1225–e1. doi:10.1016/j.ophtha.2009.02.031
  • Cheung CSY, Wong AWT, Lui A, Kertes PJ, Devenyi RG, Lam W-C. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119(8):1609–1614. doi:10.1016/j.ophtha.2012.02.014
  • Benoist d’Azy C, Pereira B, Naughton G, Chiambaretta F, Dutheil F. Antibioprophylaxis in prevention of endophthalmitis in intravitreal injection: a systematic review and meta-analysis. PLoS One. 2016;11(6):e0156431. doi:10.1371/journal.pone.0156431
  • Budzinskaya MV, Khalatyan AS, Strakhovskaya MG, Zhukhovitsky VG. Ocular flora in patients undergoing intravitreal injections: antibiotic resistance patterns and susceptibility to antiseptic picloxydine. Int J Ophthalmol. 2020;13(1):85–92. doi:10.18240/ijo.2020.01.13
  • Goldberg RA, Shah CP, Wiegand TW, Heier JS. Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes. Am J Ophthalmol. 2014;158(4):733–7.e1. doi:10.1016/j.ajo.2014.06.019
  • Diago T, Mccannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina. 2009;29(5):601–605. doi:10.1097/IAE.0b013e31819d2591
  • Friedman DA, Lindquist TP, Mason JOI, McGwin G. Needle contamination in the setting of intravitreal injections. Retina. 2014;34(5):929–934. doi:10.1097/IAE.0000000000000067
  • De Caro JJ, Ta CN, Ho H-KV, et al. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina. 2008;28(6):877–883. doi:10.1097/IAE.0b013e31816b3180
  • Tufan HA, Vural A, Gencer B, Kara S, Arikan S, Yuksel E. Bacterial contamination of needles used for intravitreal injections: comparison between 27-gauge and 30-gauge needles. Ocul Immunol Inflamm. 2013;21(5):366–370. doi:10.3109/09273948.2013.801988
  • Stewart JM, Srivastava SK, Fung AE, et al. Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm. 2011;19(1):32–38. doi:10.3109/09273948.2010.520405
  • Lytvynchuk L, Sergienko A, Savytska I, et al. Comparative cyto-histological study of needle tip aspirates and entry sites after intravitreal injection using different needle types. PLoS One. 2017;12(7):e0174467. doi:10.1371/journal.pone.0174467
  • Kucklick TR. Introduction to Needles and Cannulae. Boca Raton, FL 33487-2742: CRC Press Taylor and Francis Group; 2006:90–98.
  • Natividad A, Freeman TC, Jeffries D, et al. Human conjunctival transcriptome analysis reveals the prominence of innate defense in chlamydia trachomatis infection. Infect Immun. 2010;78(11):4895–4911. doi:10.1128/IAI.00844-10
  • Forrester JV, Docherty R, Kerr C, Lackie JM. Cellular proliferation in the vitreous: the use of vitreous explants as a model system. Invest Ophthalmol Vis Sci. 1986;27(7):1085–1094.
  • Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98(5):639–650. doi:10.1016/S0161-6420(91)32239-5
  • Scott IU, Flynn HW. Reducing the risk of endophthalmitis following intravitreal injections. Retina. 2007;27(1):10–12. doi:10.1097/IAE.0b013e3180307271
  • de Stefano VS, Abechain JJK, de Almeida LFS, et al. Experimental investigation of needles, syringes and techniques for intravitreal injections. Clin Experiment Ophthalmol. 2011;39(3):236–242. doi:10.1111/j.1442-9071.2010.02447.x
  • Brodie FL, Ruggiero J, Ghodasra DH, Hui JZ, VanderBeek BL, Brucker AJ. Volume and composition of reflux after intravitreal injection. Retina. 2014;34(7):1473–1476. doi:10.1097/IAE.0000000000000098
  • Hubschman J-P, Coffee RE, Bourges J-L, Yu F, Schwartz SD. Experimental model of intravitreal injection techniques. Retina. 2010;30(1):167–173. doi:10.1097/IAE.0b013e3181b094cf
  • Christensen L, Cerda A, Olson JL. Real-time measurement of needle forces and acute pressure changes during intravitreal injections. Clin Exp Ophthalmol. 2017;45(8):820–827. doi:10.1111/ceo.12963
  • Rodrigues EB, Grumann AJ, Penha FM, et al. Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. J Ocul Pharmacol Ther. 2011;27(2):197–203. doi:10.1089/jop.2010.0082
  • van Asten F, van Middendorp H, Verkerk S, et al. Are intravitreal injections with ultrathin 33-G needles less painful than the commonly used 30-G needles? Retina. 2015;35(9):1778–1785. doi:10.1097/IAE.0000000000000550
  • Sasajima H, Tsuboi K, Murotani K, Kamei M. Efficacy and safety of intravitreal drug injections using a short 34-gauge needle. Jpn J Ophthalmol. 2019;63(3):269–275. doi:10.1007/s10384-019-00663-w
  • Eaton AM, Gordon GM, Booth D, Wafapoor H, Avery RL, Hickingbotham D. In vivo and in vitro force testing of a new guarded injection device. Invest. Ophthalmol. Vis. Sci. 2015;56(4):2. doi:10.1167/iovs.14-14803
  • Pulido JS, Zobitz ME, An KN. Scleral penetration force requirement for commonly used intravitreal needles. Eye. 2007;21(9):1210–1211. doi:10.1038/sj.eye.6702577
  • Meyer CH, Liu Z, Brinkmann CK, Rodrigues EB, Bertelmann T. German retinal vein occlusion group. Penetration force, geometry, and cutting profile of the novel and old ozurdex needle: the MONO study. J Ocul Pharmacol Ther. 2014;30(5):387–391. doi:10.1089/jop.2013.0231
  • McGrath D Intravitreal injections: new device aims to make intravitreal injections safe and repeatable. Eurotimes. 2015;28–29.
  • Zhang Y, Bazzazi H, Lima E, et al. three-dimensional transport model for intravitreal and suprachoroidal drug injection. Invest Ophthalmol Vis Sci. 2018;59(12):5266–5276. doi:10.1167/iovs.17-23632
  • Eichenbaum D My switch to new needles for intravitreal injection. Retina Today. 2019;38–39.
  • Pearce W, Hsu J, Yeh S. Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol. 2015;26(3):233–239. doi:10.1097/ICU.0000000000000143
  • Özkaya A, Alkin Z, Celik U, et al. Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure. J Ocul Pharmacol Therap. 2013;29(3):325–329. doi:10.1089/jop.2012.0144
  • Dugel P, Bandello F, Loewenstein A. Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol. 2015;9:1321–1335. doi:10.2147/OPTH.S79948
  • Nentwich M, Yactayo-Miranda Y, Weimann S, et al. Bacterial contamination of needle points after intravitreal injection. Eur J Ophthalmol. 2009;19(2):268–272. doi:10.1177/112067210901900215
  • Nuzzi R, Scalabrin S, Becco A. Reduction of Intraocular pressure spikes due to intravitreal bevacizumab injections by scleral indentation with cotton swab or digital ocular massage: innovative techniques compared. Clin Ophthalmol. 2020;14:2533–2541. doi:10.2147/OPTH.S263474
  • Han J, Rinella NT, Chao DL. Anesthesia for intravitreal injection: a systematic review. Clin Ophthalmol. 2020;14:543–550. doi:10.2147/OPTH.S223530
  • Frenkel RE, Haji SA, La M. A protocol for the retina surgeon’s safe initial intravitreal injections. Clin Ophthalmol. 2010;4:1279–1285. doi:10.2147/OPTH.S12846
  • Tailor R, Beasley R, Yang Y, Narendran N. Evaluation of patients’ experiences at different stages of the intravitreal injection procedure – what can be improved? Clin Ophthalmol. 2011;5:1499–1502. doi:10.2147/OPTH.S24358
  • Lai TY, Liu S, Das S, Lam DS. Intravitreal injection–Technique and safety. Asia Pac J Ophthalmol (Phila). 2015;4(6):321–328. doi:10.1097/APO.0000000000000146
  • Blyth M, Innes W, Mohsin-Shaikh N, Talks JA. Comparison of conventional intravitreal injection method vs invitria intravitreal injection method. Clin Ophthalmol. 2020;14:2507–2513. doi:10.2147/OPTH.S238529
  • Soh YQ, Chiam NPY, Tsai ASH, et al. Intravitreal injection with a conjunctival injection device: a single-center experience. Trans Vis Sci Tech. 2020;9(8):28. doi:10.1167/tvst.9.8.28
  • Braun B. Spinal needle for spinal and diagnostic puncture [homepage on the Internet]. Available from: https://www.bbraun.com/en/products/b1/pencan.html. Accessed November 25, 2020.
  • Ready LB, Kozody R, Barsa JE, Murphy TM. Side-port needles for stellate ganglion block regional Anesthesia. Reg Anesth. 1982;7:160–163.
  • Gündoğar M, Sezgin GP, Kaplan SS, Özyürek H, Uslu G, Özyürek T. Postoperative pain after different irrigation activation techniques: a randomized, clinical trial. Odontology. 2020;(Epub ahead of print). doi:10.1007/s10266-020-00553-5
  • Hirata A, Yonemura N, Hasumura T, Murata Y, Negi A, Tanihara H. New infusion cannula for prevention of retinal damage by infusion air during vitrectomy. Retina. 2003;23(5):682–685. doi:10.1097/00006982-200310000-00013
  • Mi C, Petersen M, Foster R, Riemann C, Sisk R. New surgical applications for the SideFlo cannula. Retina. 2017;37(2):400–401. doi:10.1097/IAE.0000000000001270
  • Aderman CM, Rahimy E, Obeid A, et al. Comparing 33-gauge versus 30-gauge needles for intravitreal injections. Ophthalmol Retina. 2018;2(10):1078–1079. doi:10.1016/j.oret.2018.05.003
  • Muto T, Machida S. Vitreous reflux frequency and intraocular pressure after first-time intravitreal aflibercept injections: comparison of 30- and 32-gauge needles. Clin Ophthalmol. 2020;14:625–634. doi:10.2147/OPTH.S243370
  • Cernichiaro-Espinosa LA, Harper CA, Read SP, et al. Report of safety of the use of a short 32G needle for intravitreal anti–vascular endothelial growth factor injections for retinopathy of prematurity: a Multicenter Study. Retina. 2018;38(6):1251–1255. doi:10.1097/IAE.0000000000002172
  • Sasajima H, Tsuboi K, Ono H, Murotani K, Kamei M. A randomized trial of a short 34-gauge needle for intravitreal injections. Ophthalmology. 2018;125(6):947–948. doi:10.1016/j.ophtha.2018.01.038
  • Humayun M, Santos A, Altamirano JC, et al. Implantable microPump for drug delivery in patients with diabetic macular edema. Transl Vis Sci Technol. 2014;3(6):5. doi:10.1167/tvst.3.6.5
  • Rubio RG Long-Acting Anti-VEGF Delivery. Retina Today. 2014;78–80.
  • Chen ER, Kaiser PK. Therapeutic potential of the ranibizumab port delivery system in the treatment of AMD: evidence to date. Clin Ophthalmol. 2020;14:1349–1355. doi:10.2147/OPTH.S194234
  • Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci. 2003;44(3):1192–1201. doi:10.1167/iovs.02-0791
  • Haas P, Falkner-Radler C, Wimpissinger B, Malina M, Binder S. Needle size in intravitreal injections - pain evaluation of a randomized clinical trial. Acta Ophthalmol. 2016;94(2):198–202. doi:10.1111/aos.12901
  • Eaton AM, Gordon GM, Wafapoor H, Sgarlata A, Avery RL. Assessment of novel guarded needle to increase patient comfort and decrease injection time during intravitreal injection. Ophthalmic Surg Lasers Imaging Retina. 2013;44(6):561–568. doi:10.3928/23258160-20131105-06